Lexicon Pharmaceuticals
LXRX
#7250
Rank
$0.48 B
Marketcap
$1.32
Share price
0.38%
Change (1 day)
81.51%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $85.76 Million USD

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are $85.76 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.15 B11.85%
2023-12-31$0.13 B76.64%
2022-12-31$77.17 M231.02%
2021-12-31$23.31 M-50.83%
2020-12-31$47.41 M-84.23%
2019-12-31$0.30 B-3.2%
2018-12-31$0.31 B-15.68%
2017-12-31$0.36 B15.73%
2016-12-31$0.31 B-13.08%
2015-12-31$0.36 B95.41%
2014-12-31$0.18 B80.16%
2013-12-31$0.10 B-1.05%
2012-12-31$0.10 B-20.94%
2011-12-31$0.13 B10.92%
2010-12-31$0.11 B27.15%
2009-12-31$94.26 M43.52%
2008-12-31$65.68 M-20.6%
2007-12-31$82.72 M-21.04%
2006-12-31$0.10 B-21.18%
2005-12-31$0.13 B47.05%
2004-12-31$90.38 M-23.39%
2003-12-31$0.11 B270.2%
2002-12-31$31.87 M47.42%
2001-12-31$21.61 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
$2.6 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$9.21 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$1.17 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.55 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$51.86 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.81 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$3.79 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.52 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.53 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA